Neurol. praxi. 2020;21(4):296-299 | DOI: 10.36290/neu.2020.094

Diagnostic options in retrobullar neuritis

MUDr. Tereza Svrčinová
Neurologická klinika, Fakultní nemocnice a Lékařská fakulta Univerzity Palackého v Olomouci

Acute optic neuritis is the most common optic neuropathy. In its typical form, optic neuritis presents as an inflammatory demyelinating disorder of the optic nerve affecting majority of patients with multiple sclerosis (MS). Atypical forms of optic neuritis may occur, either in association with other inflammatory disorders or in isolation. Differentiation from other optic neuropathies is vital for treatment choice and further patient management to prevent visual loss. Diagnostic investigations include MRI, visual evoked potentials, and CSF examination. Over the past decade, a number of new imaging, laboratory and electrophysiological techniques have entered the clinical arena.

Keywords: optic neuritis, optical coherence tomography, multiple sclerosis, magnetic resonace imaging.

Published: September 8, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Svrčinová T. Diagnostic options in retrobullar neuritis. Neurol. praxi. 2020;21(4):296-299. doi: 10.36290/neu.2020.094.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Altinkaynak H, Duru N, Uysal BS, Erten Ş, Kürkcüoğlu PZ, Yüksel N, Duru Z, Çağil N. Choroidal thickness in patients with systemic lupus erythematosus analyzed by spectral-domain optical coherence tomography. Ocular immunology and inflammation 2016; 24(3): 254-260. Go to original source... Go to PubMed...
    2. Bride C, Courvoisier DS, Vuilleumie N, Lalive PH. Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of neurosarcoidosis. Journal of neuroimmunology 2015; 285: 1-3. Go to original source...
    3. Cramer SP, Modvig S, Simonsen HJ, Frederiksen JL, Larsson HB. Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis. Brain 2015; 138(9): 2571-2583. Go to original source...
    4. Costello F. The afferent visual pathway: designing a structural-functional paradigm of multiple sclerosis. ISRN neurology 2013. Go to original source...
    5. Diblík P. Neuritida zrakového nervu u roztroušené sklerózy mozkomíšní - typické obrazy a úskalí diferenciální diagnostiky. Neurol. praxi 2011; 12(3): 156-159.
    6. Einarsdottir AB, Hardarson SH, Kristjansdottir JV, Bragason DT, Snaedal J, Stefánsson E. Retinal oximetry imaging in Alzheimer's disease. J Alzheimers Dis. 2015; 49(1): 79-83. Go to original source...
    7. Galetta SL, et al. Acute optic neuritis Unmet clinical needs and model for new therapies. Neurology-Neuroimmunology Neuroinflammation 2015; 2(4): e135. Go to original source... Go to PubMed...
    8. Galetta SL, Villoslada P, Levin N, Shindler K, Ishikaw H, Parr E, Cadavid D, Balcer LJ. Retinal layer segmentation in patients with multiple sclerosis using spectral domain optical coherence tomography. Ophthalmology 2014; 121(2): 573-579. Go to original source...
    9. Havrdová E. Roztroušená skleróza. Čes Slov Neurol N 2008; 71/104(2): 121-132.
    10. Helmut W, Schabet M. The diagnosis and treatment of optic neuritis. Deutsches Ärzteblatt International 2015; 112(37): 616. Go to PubMed...
    11. Hradílek P, Stourac P, Bar M, Zapletalová O, Školoudík D. Colour Doppler imaging evaluation of blood flow parameters in the ophthalmic artery in acute and chronic phases of optic neuritis in multiple sclerosis. Acta Ophthalmol. 2009; 87(1): 65-70. Go to original source...
    12. Hradilek P, Školoudík D. Možnosti ultrazvukové diagnostiky v oblasti orbity. Neurol. Praxi, 2007; 8(4): 204-207.
    13. Jirásková N. Hodnocení edému zrakového nervu. Československá neurologie a neurochirurgie 2007; 70/103(5): 547-551.
    14. Kale N. Optic neuritis as an early sign of multiple sclerosis. Eye and brain 2016; 8: 195. Go to original source... Go to PubMed...
    15. Karaali K, et al. Optic neuritis: evaluation with orbital Doppler sonography. Radiology 2003; 226(2): 355-358. Go to original source... Go to PubMed...
    16. Karami M, Şenol U, Aydin H, Çevikol C, Apaydin A, Lüleci E. Orbital Doppler evaluation of blood flow velocities in optic neuritis. Korean J Ophthalmol. 2012; 26(2): 116-122. Go to original source...
    17. Katz E, Bothwell R. Working with Elders Who Have Vision Impairments. Occupational Therapy with Elders-eBook: Strategies for the COTA 2017: 217. Go to original source...
    18. Kidd DP, Burton BJ, Graham EM, Plant GT. Optic neuropathy associated with systemic sarcoidosis. Neurology-Neuroimmunology Neuroinflammation, 2016; 3(5): e270. Go to original source... Go to PubMed...
    19. Kim M, Kim H, Kwon HJ, Kim SS. Koh HJ, Lee SC. Choroidal thickness in Behcet's uveitis: an enhanced depth imaging-optical coherence tomography and its association with angiographic changes. Investigative ophthalmology & visual science 2013; 54(9): 6033-6039. Go to original source... Go to PubMed...
    20. Kubová Z, Kremláček J, Langrová J. Motion-onset VEPs: characteristics, methods, and diagnostic use. Vision Research 2007; 47(2): 189-202. Go to original source... Go to PubMed...
    21. Liu G, Bernard J. Utility of Optical Coherence Tomography Measurements as a Biomarker for Systemic Lupus Erythematosus with or without Neuropsychiatric Symptoms (P2. 299). (2014): P2-299. Poster AAN. Go to original source...
    22. Mamarabadi M, Razjouyan H, Mohammadi F, Moghaddasi M. Assessment of outcome predictors after first attack of optic neuritis. Canadian Journal of Neurological Sciences 2011; 38(6): 887-895. Go to original source... Go to PubMed...
    23. Matušková V, Lízrová Preiningerová J, Vysloužilová D, Michalec M, Kasl Z, Vlková E. Použití optické koherenční tomografie u roztroušené sklerózy. Cesk Slov Neurol N 2016; 79(1): 33-40. Go to original source...
    24. Mehta H, Sim DA, Keane PA, Zarranz-Ventura J, Gallagher K, Egan CA, Westcott M, Lee RWJ, Tufail A, Pavesio CE. Structural changes of the choroid in sarcoid-and tuberculosis-related granulomatous uveitis. Eye 2015; 29(8): 1060. Go to original source... Go to PubMed...
    25. Onal S, Uludag G, Oray M, Mengi E, Herbort CP, Akman M, Metin MM, Koc A, Aylin A, Tugal-Tutkun I. Quantitative analysis of structural alterations in the choroid of patients with active Behçet uveitis. Retina 2018; 38(4): 828-840. Go to original source...
    26. Parisi V, Manni G, Spadaro M, Colacino G, Restuccia R, Marchi S, Massimo GB, Pierelli F. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Investigative ophthalmology & visual science 1999; 40(11): 2520-2527. Go to PubMed...
    27. Pasadhika S, Rosenbaum JT. Ocular sarcoidosis. Clinics in chest medicine 2015; 36(4): 669-683. Go to original source... Go to PubMed...
    28. Qiu X, Gong L, Lu Y, Jin H, Robitaille M. The diagnostic significance of Fourier domain optical coherence tomography in Sjögren syndrome, aqueous tear deficiency and lipid tear deficiency patients. Acta ophthalmologica 2012; 90(5): e359-e366. Go to original source...
    29. Diez-Alvarez L, Casado A, Sánchez-Sánchez C, De Dompablo E, González-López JJ, Muñoz-Negrete FJ. OCT: new perspectives in neuro-ophthalmology. Saudi Journal of Ophthalmology 2015; 29(1): 9-25. Go to original source...
    30. Scott BJ, Douglas VC, Tihan T, Rubenstein JL, Josephson SA. A systematic approach to the diagnosis of suspected central nervous system lymphoma. JAMA neurology 2013; 70(3): 311-319. Go to original source... Go to PubMed...
    31. Schneck ME, Haegerstrom-Portnoy G. Color vision defect type and spatial vision in the optic neuritis treatment trial. Investigative ophthalmology & visual science 1997; 38(11): 2278-2289. Go to original source... Go to PubMed...
    32. Svrčinová T, Mareš J, Chrapek O, Šínová I, Rybariková M, Otrub P, Kaňovský P, Šín, M. Changes in oxygen saturation and the retinal nerve fibre layer in patients with optic neuritis - a pilot study. Acta ophthalmologica 96.3 (2018): e309-e314. Go to original source...
    33. Swanton JK, Fernando KT, Dalton CM, Miszkiel KA, Altmann DR, Plant GT, Thompsn AJ, Miller DH. Early MRI in optic neuritis The risk for disability. Neurology 2009; 72(6): 542-550. Go to original source... Go to PubMed...
    34. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fezekas F, Filipi M, Freedman MS, Fujihara Galleta S, Hartung P, Kappos L, Lublin FD, Ann Marie R, Miller AE, Miller D, Cohen JA. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. (2017). The Lancet Neurology Go to original source...
    35. Toosy AT, Mason DF, Miller DH. Optic neuritis. The Lancet Neurology 2014; 13(1): 83-99. Go to original source... Go to PubMed...
    36. Vaněčková M, Seidl Z. Roztroušená skleróza mozkomíšní a magnetická rezonance: současnost a nové trendy, Cesk Slov Neurol N 2008; 71/104(6): 664-672.
    37. Voss E, Raab P, Trebst C, Stangel M. Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis. Therapeutic advances in neurological disorders 2011; 4(2): 123-134. Go to original source... Go to PubMed...
    38. Výtvarná tvorba jedinců s poruchou barvocitu Masarykova Univerzita [online]. 2014 Dostupný na WWW: https://docplayer.cz/44902668-Masarykova-univerzita-vytvarna-tvorba-jedincu-s-poruchou-barvocitu.html.
    39. Waters PJ, McKeon A, Leite MI, Rajasekharan S, Lennon VA, Villalobos A, Pittock, SJ. Serologic diagnosis of NMO A multicenter comparison of aquaporin-4-IgG assays. (2012) Neurology: WNL-0b013e318248dec1. Go to original source...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.